Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M110,935Revenue $M49,384Net Margin (%)7.7Altman Z-Score2.0
Enterprise Value $M125,327EPS $4.6Operating Margin %10.0Piotroski F-Score6
P/E(ttm)28.2Beneish M-Score-2.6Pre-tax Margin (%)10.0Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %4.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %3.8Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow23.0y-y EBITDA Growth Rate %3.7ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %1.8PEG7.6ROE % (ttm)16.9Less Shares Outstanding y-yY
Payout Ratio %53.0Shares Outstanding M827ROIC % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2015-06-30 Add0.59%$139.35 - $155
($147.22)
$ 134.15-9%Add 83.74%4,610,296
BAYRYKen Fisher 2015-03-31 Add$130.2 - $155.97
($144.95)
$ 134.15-7%Add 0.63%2,509,075
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 134.15-3%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 134.15-1%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 134.1526%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 134.1573%Reduce 3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 134.1574%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 134.15124%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 134.15101%Add 24.27%46,440
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 134.15154%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 134.15154%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 134.15155%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BAYRY:

    News about BAYRY:

    Articles On GuruFocus.com
    Ken Fisher's most weighted buys in Q2 2015 Jul 28 2015 
    UnitedHealth Group Reports Strong Second Quarter Earnings Results Jul 21 2015 
    Bayer AG Wins Approval On Existing Antibiotic For Plague Treatment May 12 2015 
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    DuPont Eyeing Acquisition To Leverage Its Market Spread Apr 24 2015 
    savings Apr 22 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 

    More From Other Websites
    Making a difference: Tomorrow’s agriculture leaders finalise declaration for UN Committee on World... Sep 02 2015
    Bayer Separates Material Science Business Covestro Sep 01 2015
    Bayer AG Earnings Q2, 2015 Sep 01 2015
    Chipotle sued over GMO-free menu claims Aug 31 2015
    Bayer's Latest Stage 2 Trial Could Be A Boon For Shares Aug 31 2015
    Bayer heart failure drug cuts deaths in mid-stage trial Aug 31 2015
    Bayer to Forge Ahead With Finerenone Trials on Positive Data Aug 31 2015
    Italian farm family video wins the first global web video competition -- YouFarm International... Aug 26 2015
    Bayer Agrees to Increase Payout for Ex-Schering Shareholders Aug 25 2015
    Hunting for new ideas: 100 young leaders develop innovative actions to tackle global food challenges Aug 24 2015
    Bayer MaterialScience: 50 years of HDI production in Leverkusen Aug 21 2015
    European Commission approved Terpenoid Blend QRD 460 Aug 17 2015
    Research and Markets: Investigation Report on China's Sorafenib Market, 2010-2019 Aug 17 2015
    Covestro Management Board named Aug 13 2015
    Research and Markets: Investigation Report on China's Recombinant Factor VIII Market, 2010-2019 Aug 06 2015
    The Pesticide That Kills Bugs and Might Help Fight Cancer Aug 03 2015
    Will Regeneron (REGN) Earnings Surprise on Eylea Sales? - Analyst Blog Jul 31 2015
    Bayer (BAYRY) Q2 Revenues Up Y/Y, 2015 Guidance Revised - Analyst Blog Jul 30 2015
    Bayer reports boost in sales, income for 2Q Jul 29 2015
    Bayer Earnings Beat Estimates on Xarelto and Plastics Division Jul 29 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK